Nachrichtenübersicht

Sortierung
Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity
14.4.2026 10:59

Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity

As with any medicine, the MHRA will keep the safety and effectiveness of Wegovy under close review.

Großbritannien
Her Majesty's Revenue and Customs
Autor nicht angegeben
Pharmaindustrie, Gesundheitswesen und Krankenhäuser, Staatliche Institutionen
Cardiovascular disease risk from ionising radiation exposure
14.4.2026 10:39

Cardiovascular disease risk from ionising radiation exposure

COMARE’s 20th report reviews evidence of the risks of cardiovascular disease from exposure to ionising radiation.

Großbritannien
Her Majesty's Revenue and Customs
Autor nicht angegeben
Pharmaindustrie, Gesundheitswesen und Krankenhäuser, Wissenschaft und Forschung
Sortierung